GDC-0879
A potent and selective B-Raf kinase inhibitor with IC50 of 0.13 nM against purified B-Raf V600E and a cellular pERK IC50 of 63 nM in the MALME-3M cell line; shows expected activity only against C-Raf against a panel of 140 kinases at 1 uM; shows comparable potency in A375 melanoma and Colo205 colorectal carcinoma cell lines with IC50 of 59 nM and 29 nM for pMEK1 inhibition respectively; shows tumor growth inhibition in A375 xenografts; orally active.Skin Cancer Preclinical.
Product Specifications
CAS Number
905281-76-7
Product Name Alternative
GDC0879 | GDC 0879
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
OCCN1N=C (C2=CC=NC=C2) C (C3=CC4=C (/C (CC4) =N/O) C=C3) =C1
Molecular Formula
C19H18N4O2
Molecular Weight
334.3718
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1H-Inden-1-one, 2,3-dihydro-5-[1- (2-hydroxyethyl) -3- (4-pyridinyl) -1H-pyrazol-4-yl]-, oxime
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human NSL1 AssayLite™ Antibody (APC Conjugate)
